
|Articles|August 1, 2003
Supplements and Featured Publications
- Examining the Dyslipidemia Constellation
- Volume 9
- Issue 1 Dyslipid
IVUS is redefining atherosclerotic disease
Author(s)Steven E. Nissen, MD
Advertisement
Articles in this issue
about 22 years ago
NCEP ATP III guidelines incorporate global risk assessmentabout 22 years ago
Case reports illustrate consequences of ATP III in practiceabout 22 years ago
Inflammatory markers are useful risk assessment toolsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
2
Guideline-Directed Medical Therapies in Heart Failure
3
Responsible Use of Energy-Based Treatments on Skin of Color: Eliot F. Battle, MD
4
Collaboration in Heart Failure Treatment
5